|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 35/00 | |
| A61K 31/385 | |||
| A61K 45/06 | |||
| A61K 39/395 |
| (11) | Patento numeris | 2227296 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09701364.3 |
| Europos patento paraiškos padavimo data | 2009-01-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-09-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-11-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/030291 |
| Data | 2009-01-07 |
| (87) | Numeris | WO 2009/089260 |
| Data | 2009-07-16 |
| (30) | Numeris | Data | Šalis |
| 19778 P | 2008-01-08 | US | |
| 56957 P | 2008-05-29 | US |
| (72) |
JURE-KUNKEL, Maria, US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES |
| COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES |